Methicillin-Resistant Staphylococcus Aureus (MRSA)

0
Methicillin-Resistant Staphylococcus Aureus (MRSA)
ADVERTISEMENTS

This is a study guide for Methicillin-Resistant Staphylococcus Aureus (MRSA) which includes its nursing management, nursing assessment, selected nursing diagnoses, and nursing interventions.

What is Methicillin-Resistant Staphylococcus Aureus (MRSA)?

Staph infections—including those caused by MRSA—can spread in hospitals, other healthcare facilities, and in the community where people live, work, and go to school.

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a cause of staph infection that is difficult to treat because of resistance to some antibiotics.
  • In the community, MRSA most often causes skin infections; in some cases, it causes pneumonia (lung infection) and other infections.
  • If left untreated, MRSA infections can become severe and cause sepsis—the body’s extreme response to an infection.

Pathophysiology

Staphylococcus aureus is a gram-positive coccus that is both catalase- and coagulase-positive.

  • Staphylococcus aureus has evolved to develop numerous immune evasion strategies to combat neutrophil-mediated killing, such as neutrophil activation, migration to the site of infection, bacterial opsonization, phagocytosis, and subsequent neutrophil-mediated killing.
  • As many as 40 immune-evasion molecules of S aureus are known, and new functions are being identified for these evasion proteins.
  • They produce a range of toxins, including alpha-toxin, beta-toxin, gamma-toxin, delta-toxin, exfoliatin, enterotoxins, Panton-Valentine leukocidin (PVL), and toxic shock syndrome toxin–1 (TSST-1); enterotoxins and TSST-1 are associated with toxic shock syndrome; PVL is associated with necrotic skin and lung infections and has been shown to be a major virulence factor for pneumonia and osteomyelitis.

Statistics and Incidences

Up to 80% of people are eventually colonized with Staphylococcus aureus. Most are colonized only intermittently; 20-30% are persistently colonized.

  • Colonization rates in health care workers, persons with diabetes, and patients on dialysis are higher than in the general population.
  • The rate of MRSA hand colonization among health care workers has been shown to exceed 4% (over 8% in North America).
  • S aureus infection occurs worldwide; pyomyositis due to S aureus is more prevalent in the tropics.
  • Studies show that about one in three (33%) people carry S. aureus bacteria in their nose, usually without any illness.
  • About two in every 100 people carry MRSA; although many people carry MRSA bacteria in their nose, most do not develop serious MRSA infections.
  • Significant progress was made to reduce MRSA bloodstream infections in healthcare from 2005-2012, when the rates of MRSA bloodstream infections decreased by 17.1% each year.
  • Declines in MRSA bloodstream infections slowed from 2013-2016, when no significant change was detected.

Causes

Predisposing factors for staphylococcal infections include the following:

  • Neutropenia or neutrophil dysfunction. S aureus has evolved to develop numerous immune evasion strategies to combat neutrophil-mediated killing, such as neutrophil activation, migration to the site of infection, bacterial opsonization, phagocytosis, and subsequent neutrophil-mediated killing.
  • Diabetes. Nonhealing wounds from diabetic patients may predispose them to MRSA.
  • Intravenous drug abuse. The opioid epidemic may also be connected to the rise of staph infections in communities; people who inject drugs are 16 times more likely to develop a serious staph infection.
  • Foreign bodies, including intravascular catheters. Staphylococcal infections of prosthetic devices, including prosthetic joints and heart valves and vascular shunts, grafts, and catheters (these are increasing in incidence, most likely because of the increase in staphylococcal line-related bacteremias).
  • Trauma. Trauma with open wounds could become breeding sites for MRSA.

Clinical Manifestations

The symptoms of an MRSA infection depend on the part of the body that is infected.

  • Skin. People with MRSA skin infections often can get swelling, warmth, redness, and pain in infected skin.
  • Blood and deep tissues. Symptoms of a serious MRSA infection in the blood or deep tissues may include a fever of 100.4F or higher, chills, malaise, dizziness, confusion, muscle pain, swelling and tenderness in the affected body part, chest pain, cough, and inability to heal wounds.

Assessment and Diagnostic Findings

Methicillin-resistant Staphylococcus aureus (MRSA) is resistant to all β-lactams because of the presence of mecA, a gene that produces a pencillin binding protein (PBP2a) with low affinity for β-lactam antibiotics.

  • Cefoxitin disk diffusion test. In addition to broth microdilution testing, the Clinical and Laboratory Standards Institute (CLSI), recommends the cefoxitin disk diffusion test or a plate containing 6 μg/ml of oxacillin in Mueller-Hinton agar supplemented with 4% NaCl as alternative methods of testing for MRSA.
  • FDA-approved assays. In addition, there are FDA-approved assays for molecular detection of the mecA gene and commercially available chromogenic agars that can be used for MRSA detection.
  • Anti-PBP2A monoclonal antibodies. An alternative method for detection of MRSA is the use of anti-PBP2a monoclonal antibodies available as latex agglutination or immunochromatographic membrane assays.

Medical Management

CDC encourages clinicians to consider MRSA in the differential diagnosis of skin and soft tissue infections (SSTIs) compatible with S. aureus infections, especially those that are purulent (fluctuant or palpable fluid-filled cavity, yellow or white center, central point or “head,” draining pus, or possible to aspirate pus with needle or syringe).

  • Incision and drainage. Incision and drainage constitutes a primary therapy for furuncles, other abscesses, and septic joints, and should be performed routinely; if a clinician is unsure
    whether pus is present in a lesion, an attempt can be made to aspirate fluid from the lesion using an adequate size needle and syringe.

Pharmacological Management

Several antimicrobial agents have been proposed as alternatives to beta-lactams for outpatient treatment of SSTIs when an oral regimen with activity against MRSA is desired; these include  clindamycin, tetracyclines (including doxycycline and minocycline), trimethoprim-sulfamethoxazole (TMP-SMX), rifampin (used only in combination with other agents), and linezolid.

  • Clindamycin. Clindamycin is FDA-approved for the treatment of serious infections due to S. aureus. Although not specifically approved for the treatment of infections due to MRSA, clindamycin has been used widely in the treatment of SSTIs and there are reports of clindamycin being used successfully to treat CA-MRSA infections. 
  • Tetracyclines. Doxycycline is FDA-approved for the treatment of S. aureus skin infections, but not specifically for those caused by MRSA; there is little information in the medical literature on the use of tetracyclines for the treatment of MRSA infections; in a small case series, the long-acting tetracyclines, doxycycline and minocycline, appeared to be adequate for the treatment of MRSA SSTIs caused by tetracycline-susceptible isolates, but data were
    not sufficient to support their use in the treatment of invasive infections.
  • TMP-SMX. TMP-SMX is not FDA-approved for the treatment of any form of staphylococcal infection. However, the medical literature contains several case reports of the successful use of TMP-SMX in the treatment of S. aureus infections, including MRSA86-92. In a case-series of CA-MRSA skin infections in Los Angeles, California93, prompt resolution of symptoms was achieved in six (50%) of twelve patients initially treated with double strength TMP/SMX alone (in addition to incision and drainage of abscesses) and in all of six patients treated initially with a combination of TMP/SMX and rifampin.
  • Linezolid. Linezolid is FDA-approved for the treatment of complicated skin infections and hospital-acquired pneumonia due to MRSA in adults.

Nursing Management

Nursing care in a patient with Methicillin-resistant Staphylococcus aureus (MRSA) include the following:

Nursing Assessment

Nursing assessment for the patient with MRSA include:

  • History. Assess the patient’s health history; if there are any documented allergies.
  • Physical assessment. Assess the patient’s skin daily to ensure that the treatment being used is not causing any adverse effect to the skin.

Nursing Diagnosis

Based on the assessment data, the major nursing diagnosis for MRSA are:

  • Risk for infection related to inadequate primary defenses.
  • Impaired skin integrity related to swelling and redness that may result to a break in the skin.
  • Acute pain related to infected open wound in the affected area.
  • Impaired social interaction related to isolation.

Nursing Care Planning and Goals

The following are the major nursing care planning goals for a patient with MRSA:

  • Ensure isolation and contact transmission precautions.
  • Encourage strict hand hygiene.
  • Enforce strict use of personal protective equipment (PPE).
  • Ensure a clean environment.
  • Prevent the spread of infection.

Nursing Interventions

Listed below are the nursing interventions for a patient with MRSA:

  • Ensure isolation and contact transmission precautions. Isolate patient in a side room; keep the door closed at all times, and ensure the contact precaution sign is visible.
  • Perform hand hygiene. Ensure hand hygiene is performed using WHO 5 moments for hand hygiene; use soap and water and/or alcohol gel as appropriate; offer patient hand hygiene opportunities as appropriate; encourage patient to keep fingernails short and clean, and encourage visitors to decontaminate hands before and after visiting.
  • Use of PPEs. Wear plastic apron and gloves before entering the patient’s area; ensure PPE worn for contact with patient, environment, and equipment; request visitors to wear PPE if visiting another patient; keep PPE on while removing/disposing of used equipment, and discard PPE in a clinical waste bin before leaving the patient’s area.
  • Environmental cleaning. Use disposable mops and cloths; keep lockers and tables clear of clutter to facilitate cleaning; ensure curtains are changed if applicable; and ensure domestic staff use Chlorine Based Product (CBP) for cleaning.
  • Decontamination of patient’s equipment. Provide designated equipment where possible for the patient’s own use; clean equipment removed from their room with Tristel; keep items/equipment to a minimum within the room/patient area; all unused disposable items must be thrown away once the patient is discharged; and removed patient cutlery can be washed in the normal way.
  • Monitoring signs of infection. Check lab results and vital signs, especially temperature, every shift; document results clearly in medical and nursing notes; and inform nurse in charge/medical team of significant results.

Evaluation

Nursing goals are met as evidenced by:

  • Ensured isolation and contact transmission precautions.
  • Encouraged strict hand hygiene.
  • Enforced strict use of personal protective equipment (PPE).
  • Ensured a clean environment.
  • Prevented the spread of infection.

Documentation Guidelines

Documentation in a patient with MRSA include the following:

  • Individual findings, including factors affecting, interactions, nature of social exchanges, specifics of individual behavior.
  • Cultural and religious beliefs, and expectations.
  • Plan of care.
  • Teaching plan.
  • Responses to interventions, teaching, and actions performed.
  • Attainment or progress toward the desired outcome.

Practice Quiz: Methicillin-Resistant Staphylococcus aureus (MRSA)

Nursing practice questions for Methicillin-Resistant Staphylococcus aureus (MRSA). For more practice questions, visit our NCLEX practice questions page.

Exam Mode

In Exam Mode: All questions are shown but the results, answers, and rationales (if any) will only be given after you’ve finished the quiz.

Practice Quiz: Methicillin-Resistant Staphylococcus aureus (MRSA)

Start
Congratulations - you have completed Practice Quiz: Methicillin-Resistant Staphylococcus aureus (MRSA). You scored %%SCORE%% out of %%TOTAL%%. Your performance has been rated as %%RATING%%
Your answers are highlighted below.

Practice Mode

Practice Mode: This is an interactive version of the Text Mode. All questions are given in a single page and correct answers, rationales or explanations (if any) are immediately shown after you have selected an answer. No time limit for this exam.

Practice Quiz: Methicillin-Resistant Staphylococcus aureus (MRSA)

Start
Congratulations - you have completed Practice Quiz: Methicillin-Resistant Staphylococcus aureus (MRSA). You scored %%SCORE%% out of %%TOTAL%%. Your performance has been rated as %%RATING%%
Your answers are highlighted below.

Text Mode

Text Mode: All questions and answers are given on a single page for reading and answering at your own pace. Be sure to grab a pen and paper to write down your answers.

1. The nurse is assigned to a client who has a draining sacral wound infected by MRSA. Which personal protective equipment (PPE) will the nurse plan to use in preparing to change the linens of the client? (Select all that apply.)

1. Gloves
2. Goggles
3. Gown
4. N95 respirator
5. Surgical mask
6. Shoe covers

A. 1 and 3
B. 1, 2, and 3
C. 1, 2, and 6
D. 3, 4, and 5
E. 1, 2, 3, 4, 5, and 6

1. Answer: A. 1 and 3.

  • Option A: Prioritization. Gloves and a gown should be applied when coming in contact with linens that may be contaminated by the client’s wound secretions.
  • Options B, C, D, and E: The other PPE items are not necessary, because transmission by splashes, droplets, or airborne means will not occur when the bed is changed.

2. As the infection control nurse in an acute care hospital, which action will you take to most effectively reduce the incidence of health-care-associated infections?

A. Screen all newly admitted clients for colonization or infection with MRSA.
B. Develop policies that automatically start antibiotic therapy for clients colonized by multi-drug resistant organisms.
C. Ensure that dispensers for alcohol-based hand rubs are readily available in all client care areas of the hospital.
D. Require nursing staff to don gowns to change wound dressings for all clients.

2. Answer: C. Ensure that dispensers for alcohol-based hand rubs are readily available in all client care areas of the hospital.

  • Option C: Because the hands of health care workers are the most common means of transmission of infection from one client to another, the most effective method of preventing the spread of infection is to make supplies for hand hygiene readily available for staff to use.
  • Option A: Although some hospitals have started screening newly admitted clients for MRSA, there is no evidence that this decreases the spread of infection.
  • Option B: Because administration of antibiotics to individuals who are colonized by bacteria may promote the development of antibiotic resistance, antibiotic use should be restricted to clients who have clinical manifestations of infection.
  • Option D: Wearing a gown to care for clients who are not on contact precautions is not necessary.

3. You are preparing to change the linens on the bed of a client who has a draining sacral wound infected by MRSA. Which PPE items will you plan to use. Select all that apply.

A. Gloves
B. N95 respirator
C. Surgical Mask
D. Googles
E. Gown

3. Answer: A. Gloves, E. Gown

  • Options A & E: A gown and gloves should be used when coming in contact with linens that may be decontaminated by the client’s wound secretions.
  • Options B, C, and D: The other items are not necessary because transmission by splashes, droplets, or airborne means will not occur when the bed is changed.

4. A client with a stage 2 pressure ulcer has methicillin-resistant Staphylococcus aureus (MRSA) cultured from the wound. Contact precautions are initiated. Which rule must be observed to follow contact precautions?

A. A clean gown and gloves must be worn when in contact with the client.
B. Everyone who enters the room must wear an N-95 respirator mask.
C. All linen and trash must be marked as contaminated and send to biohazard waste.
D. Place the client in a room with a client with an upper respiratory infection.

4. Answer: A. A clean gown and gloves must be worn when in contact with the client.

  • Option A: A clean gown and gloves must be worn when any contact is anticipated with the client or with contaminated items in the room.
  • Option B: A respirator mask is required only with airborne precautions, not contact precautions.
  • Option C: All linen must be double-bagged and clearly marked as contaminated.
  • Option D: The client should be placed in a private room or in a room with a client with an active infection caused by the same organism and no other infections.

5. A client is diagnosed with methicillin-resistant staphylococcus aureus pneumonia. What type of isolation is MOST appropriate for this client?

A. Reverse isolation
B. Respiratory isolation
C. Standard precautions
D. Contact isolation

5. Answer: D. Contact isolation.

  • Option D: Contact or Body Substance Isolation (BSI) involves the use of barrier protection (e.g. gloves, mask, gown, or protective eyewear as appropriate) whenever direct contact with anybody fluid is expected. When determining the type of isolation to use, one must consider the mode of transmission. The hands of personnel continues to be the principal mode of transmission for methicillin-resistant staphylococcus aureus (MRSA). Because the organism is limited to the sputum in this example, precautions are taken if contact with the patient”s sputum is expected. A private room and BSI, along with good hand washing techniques, are the best defense against the spread of MRSA pneumonia.

References

Sources and references for this study guide for Methicillin-Resistant Staphylococcus aureus (MRSA):

  • Black, J. M., & Hawks, J. H. (2005). Medical-surgical nursing. Elsevier Saunders,. [Link]
  • Boyce, J. M., Jackson, M. M., Pugliese, G., Batt, M. D., Fleming, D., Garner, J. S., … & Williams, C. O. B. (1994). Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. Infection Control & Hospital Epidemiology15(2), 105-115. [Link]
  • Kimberlin, D. W. (2018). Red Book: 2018-2021 report of the committee on infectious diseases (No. Ed. 31). American academy of pediatrics.
  • Willis, L. (2019). Professional guide to diseases. Lippincott Williams & Wilkins. [Link]

Leave a Reply